New treatment for adults with acute lymphoblastic leukaemia

View source ↗

Summary

The EMA approved brexucabtagene autoleucel (Tecartus) for adults with acute lymphoblastic leukemia, marking the third CAR T-cell therapy approved for this high-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Tecartus (brexucabtagene autoleucel)

Snippet

Third CAR T-cell therapy for high-mortality cancer